We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal

Annals of Medicine

For an Article Collection on

Advances in the Treatment of Obesity

Manuscript deadline
31 March 2023

Cover image - Annals of Medicine

Article collection guest advisor(s)

Marc Rendell, Rose Salter Medical Research Foundation, Newport, United States
[email protected]

Ioannis Ilias, Maternity District Hospital Elena Venizelou, Athens, Greece
[email protected]

Submit an ArticleVisit JournalArticles

Advances in the Treatment of Obesity

Obesity is one of the most serious epidemiological problems of our time. The incidence of obesity has tripled since 1975, with 1.9 billion (39% of the population) adults worldwide now overweight and 650 million (13% of the population) obese. 

Obesity is a chronic metabolic disease and should be treated like all chronic diseases with a specific treatment plan, continuing therapy, and regular monitoring. The primary goal of obesity treatment is to prevent complications by keeping the patient metabolically healthy for as long as possible; to prevent or manage complications that may already be occurring; to eliminate stigma; and to restore well-being, positive body image, and self-esteem. The choice of appropriate treatment depends on two main parameters: the degree of obesity and the presence or absence of complications from the disease. Lifestyle changes, proper diet, exercise, and management of meals and sleep are the first basic steps in treating obesity. Further action for treatment includes drug therapy and bariatric surgery and some older drugs may also contribute to weight loss.

We are now entering a new age of effective pharmaceutical treatment of obesity. Several agents in the class of GLP-1 receptor agonist class have achieved a weight loss of approximately 20% in studies lasting several years. Moreover, the administration of GIP antagonists can lead to impressive weight loss. This is a development offering new hope to those afflicted with obesity, which must be viewed as a chronic disease.

In this Article Collection, we aim to assemble all recent developments in the management and treatment of obesity. We intend to solicit manuscripts on subtopics that include, but are not limited to:

  • Assessment of obesity
  • Lifestyle changes
  • Non-pharmacological management of obesity¬†
  • Pharmacological treatment of obesity
  • Bariatric surgery
  • Long-term effects of interventions for obesity

Annals of Medicine accepts the following types of articles:

  • Research Article
  • Clinical Study
  • Study Characteristics
  • Systematic Review
  • Review Article
  • Mini Review
  • Case Series

When submitting your article, please select the section, 'Endocrinology', and the Special Issue, 'Advances in the Treatment of Obesity' from the drop-down menu on the submission system.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.